RSS

combination therapy

A strategic partnership has been formed between scientists from Emulate and Roche (F Hoffman La-Roche) for the application of organ-chips in the testing of the efficacy and safety of new antibody therapeutics and combination therapies. more

News

It has been announced by Eisai that the National Institute for Health and Care Excellence (NICE) has given a positive recommendation for the use of Kisplyx (lenvatinib) in combination with everolimus for the treatment of advanced renal cell carcinoma more

News

Italian pharmaceutical company, NTC, has entered into a commercial partnership with Santen Pharmaceutical — a pharma company focused on ophthalmology. more

News

British biopharmaceuticals company, Helperby Therapeutics, has developed a sustainable solution to combat antimicrobial resistance — Antibiotic Resistance Breakers (ARBs) — which may reach the market as early as 2020. more

Technology

A study, from an international team of researchers, may offer hope to patients with prostate cancer as it shows that a combination therapy could potentially reduce the recurrence rate of the disease. more

News

Eli Lilly and Company has announced that the National Institute for Health and Care Excellence (NICE) has recommended olaratumab (Lartruvo▼) in combination with doxorubicin as a treatment for advanced soft tissue sarcoma in adults more

News

Sanofi will extend its alliance with Medicines for Malaria Venture to jointly develop a fixed-dose combination therapy for malaria, the deadliest parasitic disease in the world. more

News